Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BATTLE study of inhaled tobramycin in non-cystic fibrosis bronchiectasis
NL-OMON47248Phase 3Active, not recruiting
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in bronchiectasis comparing Tobramycin inhalation solution with Placebo (2 arms). Primary endpoint: Exacerbation reduction. Started Sep 2016; status: active, not recruiting.
02
Drugs
tobramycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NL-OMON47248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47248.